期刊文献+

恶性肿瘤合并甲状腺功能亢进的临床分析 被引量:1

Surgical therapy for malignancy patients complicated with hyperthyroidism
原文传递
导出
摘要 目的 探讨恶性肿瘤合并甲状腺功能亢进的治疗经验.方法 回顾性分析2004年5月至2010年5月天津医科大学总医院普外科收治的10例合并甲状腺功能亢进的恶性肿瘤患者的临床资料.结果 4例患者先行甲状腺次全切除术后再行肿瘤根治术,5例用药物控制甲状腺功能亢进症状后直接行肿瘤根治术,1例入院时甲状腺功能亢进已得到控制,顺利施行手术.术后3例出现类似甲状腺危象的临床表现,全组无手术死亡.术后均行化疗,其中1例因白细胞减少被迫停止化疗.结论 手术治疗合并甲状腺功能亢进的恶性肿瘤前应根据患者的不同情况选择最佳的方法(手术或药物)控制甲状腺功能亢进;合理的术前用药、有效的术后管理可以降低手术风险,使患者安全地通过围手术期;先期行甲状腺的次全切除是可行的治疗选择. Objective To summarize the therapeutic experience on malignancy patients complicated with hyperthyroidism.Methods Clinical date of 10 cases of surgical malignancy complicated with hyperthyroidism admitted from May 2004 to May 2010 in Tianjin Medical University General Hospital were analyzed retrospectively.Results Four cases were treated by subtotal thyroidectomy before radical operation for cancer.Radical operation for cancer was performed on 6 patients after clinical symptoms of hyperthyroidism were controlled by perioperative antithyroid agents.Postoperatively 3 patients complicated with clinical manifestations similar to thyroid crisis.There was no postoperative mortality.Chemotherapy was given to 10 patients,and 1 patient was discontinued for chemotherapy caused leucopenia.Conclusions Hyperthyroidism should be controlled by surgery or antithyroid agents before patients of malignant diseases could proceed with radical surgery.Proper preoperative medication and effective postoperative management can reduce operation risk and help the patients get through the perioperative period safely.
出处 《中华普通外科杂志》 CSCD 北大核心 2012年第1期21-24,共4页 Chinese Journal of General Surgery
关键词 甲状腺功能亢进症 肿瘤 手术期间 抗肿瘤联合化疗方案 Hyperthyroidism Neoplasms Intraoperative period Antineoplastic combined chemotherapy protocols
  • 相关文献

参考文献10

  • 1Ness RB,Grisso JA,Cottreau C,et al.Factors related to inflammation of the ovarian epithelium and risk of ovarian cancer.Epidemiology,2000,11:111-117.
  • 2Ko AH,Wang F,Holly EA.Pancreatic cancer and medical history in a population-based case-control study in the San Francisco Bay Area,California.Cancer Causes Control,2007,18:809-819.
  • 3Kearney T,Dang C.Diabetic and endocrine emergencies.Postgrad Med J,2007,83:79-86.
  • 4Boger MS,Perrier ND.Advantages and disadvantages of surgical therapy and optimal extent of thyroidectomy for the treatment of hyperthyroidism.Surg Clin N Am,2004,84:849-874.
  • 5Sarlis NJ,Gourgiotis L.Thyroid emergencies.Rev Endocr Metab Disord,2003,4:129-136.
  • 6何永忠,黄超有,陈建强.不同术前准备方法对甲状腺功能亢进症术中心血管反应的影响[J].广东医学,2004,25(11):1303-1304. 被引量:2
  • 7Huang CH,Li KL,Wu JH,et al.Antithyroid drug-induced agranulocytosis:report of 13 cases.Chang Gung Med J,2007,30:242-248.
  • 8Kahara T,Yoshizawa M,Nakaya I,et al.Thyroid crisis following interstitial nephritis.Inter Med,2008,47:1237-1240.
  • 9Ron E,Doody MM,Becker DV,et al.Cancer mortality following treatment for adult hyperthyroidism.JAMA,1998,280:347-355.
  • 10Van der Bol JM,Visser TJ,Loos WJ,et al.Effects of mathimazole on the elimination of irinotecan.Cancer Chemother Pharmacol,2011,67:231-236.

二级参考文献3

共引文献1

同被引文献7

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部